Related Experiment Video
Updated: Aug 7, 2026

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
Expression of actin mutants to study their roles in cardiomyopathy
Lori A Rutkevich1, David J Teal, John F Dawson
1Department of Molecular and Cellular Biology, University of Guelph, ON, Canada.
Abstract:
Mutations in the human cardiac actin gene (ACTC) have been implicated in the development of hypertrophic or dilated cardiomyopathy in humans. To determine the molecular mechanism for the disease development, a system for the expression of mutant cardiac actin proteins that may be lethal to eukaryotic cells must be developed. Here, we explore some of the advantages and disadvantages of human ACTC expression in yeast and insect cells. We show that human ACTC is incapable of rescuing a yeast endogenous actin (ACT1)-knockout in yeast cells and that coexpression of human ACTC in yeast results in slower growth, making yeast an unsuitable expression system. However, we show that it is possible for yeast cells to express a polymerization-deficient ACTI mutant, thereby allowing us to examine the cell biology of this mutation in the future. Finally, mutant forms of human cardiac actin can be expressed in and purified from insect cells in a properly folded and functional form, permitting important characterization of the biochemical mechanisms responsible for cardiomyopathy development in humans. These studies allow for further research into the biochemical characteristics of previously untenable actin mutant proteins.
Insights
Human cardiac actin (ACTC) mutations cause cardiomyopathy. Yeast is unsuitable for studying lethal ACTC mutations, but insect cells can express functional mutant cardiac actin for disease mechanism research.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Mutations in the human cardiac actin gene (ACTC) are linked to cardiomyopathy.
- Understanding the molecular mechanisms of these mutations requires expressing mutant actin proteins.
Purpose of the Study:
- To evaluate yeast and insect cells as expression systems for human cardiac actin (ACTC) mutants.
- To establish a system for studying the biochemical mechanisms of actin-related cardiomyopathies.
Main Methods:
- Assessed human ACTC expression and function in yeast cells, including rescue of an endogenous actin knockout.
- Investigated the possibility of expressing a polymerization-deficient ACTI mutant in yeast.
- Developed a method for expressing and purifying functional mutant human cardiac actin in insect cells.
Main Results:
- Human ACTC could not rescue yeast actin knockout and impaired yeast growth, indicating yeast is unsuitable for lethal ACTC mutants.
- Yeast can express a polymerization-deficient ACTI mutant for future cell biology studies.
- Insect cells successfully expressed properly folded and functional mutant human cardiac actin.
Conclusions:
- Insect cells are a viable system for expressing and characterizing human cardiac actin mutants relevant to cardiomyopathy.
- This system enables further research into the biochemical basis of actin-related heart diseases.
- Yeast is not suitable for studying potentially lethal human cardiac actin mutations.
Related Concept Videos
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Introduction to Actin
The Role of Actin and Myosin in Non-muscle Cells
Cardiomyopathy III: Hypertrophic Cardiomyopathy
